| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 114.690 | 95.887 | 89.021 | 99.990 | 98.439 | 111.491 | 114.956 | 141.282 | 156.280 | 180.394 |
| Total Income - EUR | 114.707 | 95.901 | 89.037 | 100.022 | 98.444 | 111.528 | 115.004 | 141.464 | 156.303 | 180.668 |
| Total Expenses - EUR | 117.529 | 98.753 | 95.053 | 94.931 | 90.615 | 97.999 | 100.287 | 125.971 | 138.094 | 159.108 |
| Gross Profit/Loss - EUR | -2.823 | -2.852 | -6.016 | 5.091 | 7.829 | 13.529 | 14.717 | 15.493 | 18.209 | 21.560 |
| Net Profit/Loss - EUR | -3.284 | -3.289 | -6.907 | 4.100 | 6.844 | 12.414 | 13.567 | 14.078 | 16.646 | 17.780 |
| Employees | 5 | 4 | 4 | 0 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Pharmis Consulting Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.915 | 766 | 127 | 411 | 362 | 894 | 715 | 957 | 516 | 308 |
| Current Assets | 54.386 | 29.869 | 30.941 | 28.577 | 30.487 | 47.595 | 51.290 | 60.104 | 57.978 | 56.181 |
| Inventories | 20.712 | 13.397 | 12.280 | 11.908 | 15.356 | 28.977 | 31.102 | 35.579 | 34.194 | 39.060 |
| Receivables | 10.401 | 2.439 | 8.004 | 8.247 | 7.273 | 9.997 | 11.590 | 14.943 | 17.342 | 11.114 |
| Cash | 23.272 | 14.033 | 10.657 | 8.421 | 7.859 | 8.621 | 8.598 | 9.582 | 6.442 | 6.008 |
| Shareholders Funds | 19.715 | 3.716 | -3.253 | 906 | 7.733 | 20.000 | 27.817 | 35.578 | 37.283 | 39.777 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 36.609 | 26.919 | 33.879 | 28.081 | 23.116 | 28.489 | 24.188 | 25.484 | 21.210 | 16.712 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Pharmis Consulting Srl